Statistics for Moderna (id:7088 MRNA)

Valuation metrics

Market cap

15.82B

Enterprise value

9.21B

Trailing P/E (ttm)

24.97

Forward P/E

-4.73

PEG ratio

-4.73

Price/Sales (ttm)

3.11

Price/Book (mrq)

1.33

Enterprise Value/Revenue

1.81

Enterprise Value/EBITDA

-3.90

Overview

Shares outstanding

384.82M

Float

347.53M

Shares short

34.38M

% Held by insiders

0.10%

% Held by institutions

0.72%

Average volume (10 days)

12.36M

Average volume (90 days)

Price summary

52-Week low

35.80

52-Week high

170.47

52-Week change

-88.87%

Beta

1.69

50-Day moving average

55.50

200-Day moving average

96.37

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-43.77%

Operating margin

-3.76%

Operational effectiveness

Return on assets

-9.55%

Return on equity

-17.52%

Income statement

Revenue (ttm)

13.28

Revenue per share (ttm)

13.28

Quarterly revenue growth (yoy)

Gross profit (ttm)

2.06B

EBITDA

-2,361,999,872.00

Net income to common (ttm)

-2,224,000,000.00

Diluted EPS (ttm)

-5.81

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

6.87B

Total cash per share (mrq)

17.84

Total debt (mrq)

1.36B

Total Debt/Equity (mrq)

11.36

Current ratio (mrq)

439.20%

Book value per share (mrq)

30.98

Cash flow

Cash flow statement

-3,207,000,064.00

Levered free cash flow (LFCF)

-3,337,125,120.00